ArticleJournal of cancer research and clinical oncology2024

Effective bridging strategies prior to infusion with tisagenlecleucel results in high response rates and long-term remission in relapsed/refractory large B-cell lymphoma: findings from a German monocentric study.

Farina Eigendorff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.